CPRX
CPRX
NASDAQ · Biotechnology

Catalyst Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$23.32
+0.53 (+2.33%)
As of Mar 24, 1:21 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +115.0% upside
Low Target $36.48
Average Target $50.13
High Target $69.47
Current Price $23.32
Current
$23.32
Target
$50.13
$36.48 $50.13 avg $69.47
Scenario Analysis
Bear Case
$36.48
56.4%
Low target
Base Case
$50.13
+115.0%
Avg target
Bull Case
$69.47
+197.9%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$26.58
-12.3% from high
52-Week Low
$19.05
+22.4% from low
50-Day SMA
$23.76
-1.9% vs SMA
200-Day SMA
$22.30
+4.6% vs SMA
RSI (14)
48.5
Neutral
Target vs 52W High
$50.13
+88.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%